कृपया अन्य खोज का प्रयास करें
AIM Vaccine Co., Ltd. engages in the research and development, manufacturing, and commercialization of vaccine products for human use in the People’s Republic of China. The company’s product pipeline includes Bivalent Delta-Omicron BA.5 mRNA and Monovalent Omicron BA.5 mRNA, which is in phase III clinical trails for the treatment of COVID-19; EV71-CA16 Bivalent for HFMD; and Valent Pneumococcal Conjugate and Polysaccharide vaccine for pneumococcal disease. It also offers Hexavalent group B Streptococcus Polysaccharide Conjugate Vaccine for Group B strep disease; Diphtheria, Tetanus and Pertussis and Haemophilus In¬uenzae type B, and Diphtheria, Tetanus and Acellular Pertussis, and Absorbed Tetanus for DTP; Haemophilus In¬uenzae Type B for Hib; and freeze-dried human rabies and mRNA human rabies vaccine. In addition, the company develops Human Papillomavirus 2 and 3-valent vaccine; Tetravalent Meningococcal Conjugate vaccine; Tetravalent In¬uenzae vaccine; mRNA Shingles/Herpes Zoster vaccine; mRNA respiratory syncytial virus vaccine; live attenuated parotitis vaccine; and ACYW135 meningococcal polysaccharide vaccine. The company was formerly known as Beijing AIM Biological Vaccine Technology Group Co., Ltd. and changed its name to AIM Vaccine Co., Ltd. in September 2020. AIM Vaccine Co., Ltd. was incorporated in 2011 and is headquartered in Beijing, the People’s Republic of China.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Song Jiashuai | 27 | 2020 | Employee Representative Supervisor |
Jichen Zhao | 58 | 2020 | Non-Executive Director |
Aijun Wang | 51 | 2017 | Non-Executive Director |
Jie Wen | 59 | 2021 | Independent Non-Executive Director |
Lun Ma | 61 | 2015 | Supervisor |
Yan Zhou | 56 | 2015 | Executive Chairman & CEO |
Hui Ouyang | 62 | 2021 | Independent Non-Executive Director |
Shaojun Jia | 60 | 2017 | COO, Executive President & Executive Director |
Ker Wei Pei | 67 | 2020 | Independent Non-Executive Director |
Wen Guan | 56 | 2021 | Vice-Chairman of the Board & Executive President |
Jie Zhou | 59 | 2015 | Non-Executive Director |
Xin Zhou | 54 | 2013 | Executive Vice-Chairman of the Board |
Tingfeng Song | 55 | 2021 | Chairman of The Supervisory Committee |
Xiaoguang Guo | 50 | 2021 | Independent Non-Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है